Satellos Bioscience Inc.

Satellos Bioscience Inc. (MSLE) showed no cyber incidents or major red-flag 8-K filings in the past 90 days, suggesting stable near-term operational continuity. However, absence of recent events does not indicate absence of risk; biotech companies face structural pressures from equity dilution, clinical-stage financing dependency, and cash burn patterns that require longer-term visibility. The full $49 Report extends analysis to 12 months of filings, calculates dilution risk scoring, maps financing history and runway concerns, and flags AI-detected risk signals across SEC documents. The full $49 Report adds comprehensive dilution analysis, detailed 8-K context, financing runway assessment, and AI risk signals across a 12-month window.